Profile picture for user andreich
Andrei Chirileasa
Editor-in-Chief

Andrei studied finance at the Bucharest Academy of Economic Studies and started his journalism career in 2004 with Ziarul Financiar, the leading financial newspaper in Romania, where he worked for ten years, the last six of which as editor of the capital markets section. He joined the Romania-Insider.com team in 2014 as editor and became Editor-in-Chief in 2016. He currently oversees the daily content published on Romania-Insider.com and likes to stay up to date with everything relevant in business, politics, and life in Romania. Andrei lives with his family in the countryside in Northern Romania, where he built their own house. In his free time, he studies horticulture and tends to his family’s garden. He enjoys foraging in the woods and long walks on the hills and valleys around his village. Email him for story ideas and interviews at andrei@romania-insider.com. 

 

Romanian pharma producer Antibiotice wins EUR 11 mln contract in the UK

Romanian medicines producer Antibiotice Iași won the tender organized by the United Kingdom's Ministry of Health for five injectable anti-infective products (intended for hospitals) used to treat bacterial superinfections associated with Covid-19, the company announced in a post on its Facebook page.

The contract will run for two years, and the first deliveries will be made in January 2022 without endangering the provision of drugs for all hospitals in Romania.

In recent years, Antibiotice has won major tenders for anti-infective drugs in the United States, where it holds a large market share, Western Europe, south-east Asia and the auction organized by the European Commission (2020), which ensures member states' stocks of beta-lactam antibiotics during the pandemic.

Antibiotice Iași is controlled by the Romanian state through the Ministry of Health.

(Photo: Antibiotice Iasi Facebook Page)

andrei@romania-insider.com

Normal
Profile picture for user andreich
Andrei Chirileasa
Editor-in-Chief

Andrei studied finance at the Bucharest Academy of Economic Studies and started his journalism career in 2004 with Ziarul Financiar, the leading financial newspaper in Romania, where he worked for ten years, the last six of which as editor of the capital markets section. He joined the Romania-Insider.com team in 2014 as editor and became Editor-in-Chief in 2016. He currently oversees the daily content published on Romania-Insider.com and likes to stay up to date with everything relevant in business, politics, and life in Romania. Andrei lives with his family in the countryside in Northern Romania, where he built their own house. In his free time, he studies horticulture and tends to his family’s garden. He enjoys foraging in the woods and long walks on the hills and valleys around his village. Email him for story ideas and interviews at andrei@romania-insider.com. 

 

Romanian pharma producer Antibiotice wins EUR 11 mln contract in the UK

Romanian medicines producer Antibiotice Iași won the tender organized by the United Kingdom's Ministry of Health for five injectable anti-infective products (intended for hospitals) used to treat bacterial superinfections associated with Covid-19, the company announced in a post on its Facebook page.

The contract will run for two years, and the first deliveries will be made in January 2022 without endangering the provision of drugs for all hospitals in Romania.

In recent years, Antibiotice has won major tenders for anti-infective drugs in the United States, where it holds a large market share, Western Europe, south-east Asia and the auction organized by the European Commission (2020), which ensures member states' stocks of beta-lactam antibiotics during the pandemic.

Antibiotice Iași is controlled by the Romanian state through the Ministry of Health.

(Photo: Antibiotice Iasi Facebook Page)

andrei@romania-insider.com

Normal
 

facebooktwitterlinkedin

1

Romania Insider Free Newsletters